Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Pulmonary Hypertension
Clinical trial register · Germany

Pulmonary Hypertension Trials in Germany, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5062 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:18 UTC
5062
Studies in scope
all four open statuses
2869
Recruiting now
open to new participants
983
Lead sponsors
across recruiting studies
Top sites
Giessen 4 Heidelberg 4 Dresden 4 München 3 Stuttgart 2

Pulmonary Hypertension trials in Germany

14 of 5062 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Recruiting
Insmed Incorporated
Phase 3
344
Gauting, München
2026-07-20
Recruiting
Insmed Incorporated
Phase 3
344
Heidelberg, Immenhausen, Stuttgart, München, Bonn, Essen, Homburg, Dresden
2026-01-07
Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
NCT06526195Heart Failure, Heart Diseases, Cardiovascular Diseases, Pulmonary Hypertension
Abbott Medical Devices
Not applicable
850
Leipzig, Hanover, Berlin
2024-12-13
Active, closed
A Study of Mosliciguat in PH-ILD
NCT06635850Pulmonary Hypertension, Interstitial Lung Disease, Lung Diseases, Vascular Diseases
Pulmovant, Inc.
Phase 2
135
Heidelberg, München, Dresden, Halle
2024-10-29
Active, closed
Tectonic Therapeutic
Phase 2
191
Mainz
2024-09-04
Recruiting
Association Between Biomarkers and Kidney Function Decline in Pulmonary Hypertension
NCT06409624Pulmonary Hypertension, Chronic Kidney Disease
University of Giessen
Observational
400
Bad Nauheim, Giessen
2024-05-31
Recruiting
Digital Assessment of Real-World Walking Activity in Pulmonary Hypertension: A Prospective Multicenter Trial
NCT07137260Pulmonary Hypertension, Precapillary Pulmonary Hypertension, Right Heart Catheterisation, Digital Mobility Outcomes
Simon Jäger
Observational
77
Stuttgart, Munich, Nuremberg, Löwenstein
2024-04-19
Recruiting
Diaphragmatic Function as a Biomarker
NCT05903001Dyspnea; Asthmatic, COPD, Fibrosis, Pulmonary Hypertension
RWTH Aachen University
Observational
800
Aachen
2023-07-01
Active, closed
Merck Sharp & Dohme LLC
Phase 2
129
Heidelberg, Giessen, Hanover, Dresden, Lübeck
2023-03-16
Recruiting
Ayham Daher
Observational
100
Aachen
2021-06-25
Recruiting
Universitätsklinikum Hamburg-Eppendorf
Observational
5,000
Hamburg
2021-01-26
Recruiting
PVRI GoDeep Global Deep Phenotyping Meta-Registry for Pulmonary Hypertension
NCT05329714Pulmonary Hypertension, Global Health
University of Giessen
Observational
40,000
Giessen
2020-01-30
By invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT03683186PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension
United Therapeutics
Phase 3
1,000
Heidelberg, Greifswald, Mainz, Homburg, Leipzig, Donaueschingen, Dresden, Hamburg
2019-09-23
Recruiting
Giessen Pulmonary Hypertension Registry and Biobank
NCT04145024Pulmonary Hypertension
University of Giessen
Observational
10,000
Giessen
1993-07
Rows per page Showing 1–14 of 14
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-germany/condition/pulmonary-hypertension

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,062 studies in total at the last sync on 10 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 14 of those studies listing the condition Pulmonary Hypertension.

How many Pulmonary Hypertension trials are recruiting in Germany?

10 of the 14 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 3 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Pulmonary Hypertension), 14 studies
PhaseStudiesRecruitingShare
Observational7750%
Phase 23021.4%
Phase 33221.4%
Not applicable117.1%

Most active sponsors

Lead sponsors with the most studies (Pulmonary Hypertension)
Lead sponsorStudiesRecruiting
University of Giessen33
Insmed Incorporated22
Abbott Medical Devices11
Ayham Daher11
Merck Sharp & Dohme LLC10
Pulmovant, Inc.10
RWTH Aachen University11
Simon Jäger11
Tectonic Therapeutic10
United Therapeutics10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.